MALAT1 and melanoma: As already seen in the normalized data, MALAT1 expression was significantly decreased in BRAF- and NRAS-mutated melanoma (13.5-fold, p < 0.001, Figure 4E), LIHC (3.3-fold, p < 0.001, Figure 4F) and LUSC (8.7-fold, p < 0.001, Figure 4H), when compared to their corresponding healthy tissue.